Enanta Pharmaceuticals (ENTA) Asset Utilization Ratio (2013 - 2026)

Enanta Pharmaceuticals (ENTA) has 14 years of Asset Utilization Ratio data on file, last reported at 0.21 in Q1 2026.

• Quarterly Asset Utilization Ratio rose 11.94% year-over-year to 0.21 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.21 (up 11.94% YoY) and the FY2025 annual result came in at 0.2, up 23.26% from the prior year.
• Asset Utilization Ratio retreated to 0.21 in Q1 2026, from 0.22 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.24 in Q1 2023 to a low of 0.17 in Q4 2023.
• A 5-year average of 0.2 and a median of 0.21 in 2025 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2024 — Asset Utilization Ratio retreated 28.14% — and 2025, when it increased 28.74%.
• Tracing ENTA's Asset Utilization Ratio over 5 years: stood at 0.23 in 2022, then slipped by 27.22% to 0.17 in 2023, then rose by 11.09% to 0.18 in 2024, then increased by 19.55% to 0.22 in 2025, then declined by 2.12% to 0.21 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.21 (Q1 2026), 0.22 (Q4 2025), and 0.22 (Q3 2025), per Business Quant data.